P. M. Williams

发表

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

S. Shurtleff, J. D. Vos, L. Rassenti, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Application of molecular profiling in clinical trials for advanced metastatic cancers.

Yingdong Zhao, Chih-Jian Lih, James H Doroshow, 2015, Journal of the National Cancer Institute.

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Kai Fu, Raymond R Tubbs, Jan Delabie, 2014, Blood.

Criteria for the use of omics-based predictors in clinical trials

Jill P. Mesirov, William L. Bigbee, James H. Doroshow, 2013, Nature.

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

Jill P Mesirov, Lisa M McShane, James H Doroshow, 2013, BMC Medicine.

Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue.

Yanxiang Cao, Stephen M Hewitt, M. Cronin, 2009, Archives of pathology & laboratory medicine.

Multilaboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements

Jessica L. Larson, Brian C. Haynes, T. Godfrey, 2019, The Journal of molecular diagnostics : JMD.

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.

S. Luoh, R. Gray, K. Flaherty, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

D. Parsons, N. Ramirez, T. Alonzo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy

P. M. Williams, A. Ganguly, M. Sachs, 2017, PloS one.

State of the Science and Future Directions for Liquid Biopsies in Drug Development.

Reena Philip, G. Kelloff, P. M. Williams, 2020, The oncologist.

The beginnings of real-time PCR.

P. M. Williams, P. Williams, 2009, Clinical chemistry.

Abstract 5671: Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Brett J. Kennedy, Lisa M Haley, Mingchao Xie, 2020 .

Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors

P. M. Williams, S. Mueller, R. Packer, 2022, npj Precision Oncology.

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B.

Carlos L. Arteaga, R. Gray, K. Flaherty, 2022, JCO precision oncology.

Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods.

David J. Sims, S. Lund, J. Almeida, 2016, The Journal of molecular diagnostics : JMD.

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

J. Downing, S. Shurtleff, J. D. Vos, 2008 .

Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome.

Torsten Haferlach, Alexander Kohlmann, Wolf-Karsten Hofmann, 2009, Blood.

Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory Study.

Bharathi Anekella, Helen Fernandes, Andrea Ferreira-Gonzalez, 2017, The journal of applied laboratory medicine.

Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

S. Steinberg, A. Oza, J. Doroshow, 2015, Clinical Cancer Research.

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Roland Schmitz, Chih-Jian Lih, L. Staudt, 2015, Nature Medicine.

Differential Outcomes in Codon 12/13 and Codon 61 NRAS-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with NRAS-Mutated Tumors

R. Gray, K. Flaherty, L. Rubinstein, 2021, Clinical Cancer Research.

Ado-trastuzumab emtansine (T-DM1) in patients with HER2 amplified tumors excluding breast and gastric/gastro-esophageal junction (GEJ) adenocarcinomas: Results from the NCI-MATCH Trial (EAY131) Sub-protocol Q.

S. Luoh, R. Gray, K. Flaherty, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository

Yvonne A. Evrard, L. McShane, J. Doroshow, 2021, Journal of Translational Medicine.

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial.

Lisa M McShane, Robin D Harrington, Chih-Jian Lih, 2017, The Journal of molecular diagnostics : JMD.

Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms: Phase 2 of the Friends of Cancer Research TMB Harmonization Project.

A. Stenzinger, J. Budczies, Mingchao Xie, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

L. Staudt, R. Gascoyne, G. Salles, 2017, Clinical Cancer Research.

Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression

S. Hayward, R. Soriano, P. M. Williams, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

C. Paweletz, K. Cole, J. Barrett, 2021, JCO precision oncology.

Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements

Steven P. Lund, S. Lund, J. Almeida, 2019, Clinical chemistry and laboratory medicine.

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

N. Ramirez, T. Alonzo, M. Mooney, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.

R. Gray, K. Flaherty, L. Rubinstein, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacodynamic biomarker-driven trial of MK-2206, an AKT inhibitor, with AZD6244 (selumetinib), a MEK inhibitor, in patients with advanced colorectal carcinoma (CRC).

L. Rubinstein, J. Doroshow, P. M. Williams, 2012 .

Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

R. Gray, K. Flaherty, L. Rubinstein, 2020, Clinical Cancer Research.

A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays.

R. Gascoyne, George W. Wright, N. Johnson, 2010, The Journal of molecular diagnostics : JMD.

Clinical Applications of Next-Generation Sequencing in Precision Oncology

P. M. Williams, C. Karlovich, P. Williams, 2019, Cancer journal.